FindTrial
Sign In

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00549289
Enrollment
Unknown
Registered
2007-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2007-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndromes

Brief summary

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Interventions

DRUGcyclosporine A

Sponsors

Sirion Therapeutics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum

Inclusion criteria

* Diagnosis of dry eye syndrome

Exclusion criteria

* Intraocular or refractive surgery in the study eye within 3 months prior to study start * Unwilling to discontinue use of contact lenses during the study * Pregnancy or lactation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026